xamoterol has been researched along with Cardiomyopathy, Congestive in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cruickshank, JM | 1 |
| Hirokawa, Y; Izumi, T; Masani, F; Otsuka, H; Shibata, A; Suzuki, K; Watanabe, K | 1 |
| Hirokawa, Y; Masani, F; Otsuka, H; Shibata, A; Suzuki, K; Watanabe, K | 1 |
| Oakley, C; Pouleur, H; Rousseau, MF; Rydén, L | 1 |
| Hasenfuss, G; Heiss, HW; Holubarsch, C; Just, H; Thierfelder, L | 1 |
| Boström, PA; Johansson, BW; Lecerof, H; Lilja, B; Torp, A | 2 |
| Hasenfuss, G; Holubarsch, CH; Just, HJ; Thierfelder, L | 1 |
| Fukuda, K; Handa, S; Kawamura, Y; Nakamura, Y; Ogawa, S | 1 |
| Bhatia, SJ; Chatterjee, K; Swedberg, K | 1 |
| Amende, I; Hood, WP; Lichtlen, PR; Simon, R | 1 |
| Hirokawa, Y; Shibata, A; Watanabe, K | 1 |
| Hirokawa, Y; Shibata, A; Suzuki, K; Watanabe, K | 1 |
1 review(s) available for xamoterol and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
The xamoterol experience in the treatment of heart failure.
Topics: Cardiac Output, Low; Cardiomyopathy, Dilated; Humans; Xamoterol | 1993 |
2 trial(s) available for xamoterol and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study.
Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Captopril; Cardiomyopathy, Dilated; Cause of Death; Double-Blind Method; Drug Interactions; Enalapril; Female; Follow-Up Studies; Humans; Life Tables; Male; Middle Aged; Probability; Propanolamines; Xamoterol | 1991 |
Effect of xamoterol on exercise capacity and left ventricular function in angina pectoris and in dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Aged; Angina Pectoris; Cardiomegaly; Cardiomyopathy, Dilated; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Ventricles; Humans; Male; Middle Aged; Propanolamines; Stroke Volume; Xamoterol | 1989 |
10 other study(ies) available for xamoterol and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Risk factors and the effects of xamoterol in idiopathic dilated cardiomyopathy.
Topics: Adolescent; Adult; Aged; Cardiomyopathy, Dilated; Child; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardium; Prospective Studies; Risk Factors; Stroke Volume; Survival Rate; Tachycardia, Ventricular; Xamoterol | 1992 |
Effects of long-term xamoterol in idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Adult; Aged; Cardiomyopathy, Dilated; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Prognosis; Propanolamines; Prospective Studies; Pulmonary Wedge Pressure; Stroke Volume; Survival Rate; Time Factors; Xamoterol | 1992 |
The effect of the partial beta-1-adrenoceptor agonist xamoterol on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Coronary Circulation; Energy Metabolism; Female; Heart; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Propanolamines; Xamoterol | 1991 |
Effect of xamoterol on exercise capacity and left ventricular function in angina pectoris and in dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Cardiomyopathy, Dilated; Heart; Humans; Physical Exertion; Propanolamines; Xamoterol | 1990 |
Myocardial energetics in dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Circulation; Enoximone; Heart; Heart Failure; Heart Rate; Humans; Imidazoles; Myocardium; Nitroprusside; Oxygen Consumption; Phosphodiesterase Inhibitors; Propanolamines; Pyridazines; Stroke Volume; Vascular Resistance; Vasodilator Agents; Xamoterol | 1990 |
[How to select newly-developed oral inotropic agents: an evaluation based on their effects on heart rate and arrhythmias].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Dilated; Cardiotonic Agents; Circadian Rhythm; Digitalis; Drug Evaluation; Electrocardiography, Ambulatory; Ethanolamines; Female; Heart Rate; Humans; Male; Middle Aged; Plants, Medicinal; Plants, Toxic; Propanolamines; Pyrazines; Quinolines; Xamoterol | 1990 |
Acute hemodynamic and metabolic effects of ICI 118,587 (Corwin), a selective partial beta 1 agonist, in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Adult; Aged; Cardiomyopathy, Dilated; Catecholamines; Coronary Circulation; Female; Hemodynamics; Humans; Lactates; Male; Middle Aged; Myocardium; Propanolamines; Xamoterol | 1986 |
[Acute effect of the cardioselective beta-1-partial agonist, Corwin, on ventricular function and myocardial oxygen consumption in patients with dilated cardiomyopathy].
Topics: Adrenergic beta-Agonists; Adult; Cardiac Output; Cardiomyopathy, Dilated; Female; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Propanolamines; Sympathetic Nervous System; Xamoterol | 1986 |
Xamoterol in patients with dilated cardiomyopathy: an increase in beta-receptors in lymphocytes.
Topics: Adaptation, Physiological; Adrenergic beta-Agonists; Adult; Cardiomyopathy, Dilated; Female; Heart Failure; Hemodynamics; Humans; Lymphocytes; Male; Middle Aged; Physical Exertion; Propanolamines; Receptors, Adrenergic, beta; Xamoterol | 1988 |
Acute and chronic effects of xamoterol in idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Echocardiography; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Physiologic; Propanolamines; Time Factors; Xamoterol | 1988 |